Mackenzie Financial’s Guardant Health GH Stock Holding History

Mackenzie Financial’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-59,025	Closed	-$5.45M	–	1606
2026 Q1	$5.45M	Buy	59,025 +23,002	+64%	+$2.31M	0.01%	641
2025 Q4	$3.62M	Buy	36,023 +13,172	+58%	+$1.18M	﹤0.01%	707
2025 Q3	$1.43M	Buy	22,851 +15,211	+199%	+$827K	﹤0.01%	952
2025 Q2	$398K	Buy	7,640 +114	+2%	+$5.09K	﹤0.01%	1300
2025 Q1	$321K	Hold	7,526	–	–	﹤0.01%	1364
2024 Q4	$230K	Sell	7,526 -2,283	-23%	-$64.2K	﹤0.01%	1500
2024 Q3	$225K	Buy	9,809 +2,831	+41%	+$80.1K	﹤0.01%	1326
2024 Q2	$202K	Buy	+6,978	New	+$162K	﹤0.01%	1341
2023 Q4	–	Sell	-6,978	Closed	-$201K	–	1538
2023 Q3	$201K	Hold	6,978	–	–	﹤0.01%	1275
2023 Q2	$247K	Buy	+6,978	New	+$200K	﹤0.01%	1248
2021 Q2	–	Sell	-4,160	Closed	-$635K	–	1252
2021 Q1	$635K	Buy	4,160 +740	+22%	+$112K	﹤0.01%	887
2020 Q4	$441K	Buy	+3,420	New	+$394K	﹤0.01%	864

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Mackenzie Financial's GH Position: Q2 2026 in Review

Mackenzie Financial sold out of Guardant Health (GH) in Q2 2026, closing a stake of 59,025 shares — an estimated $5.45M sold.

Mackenzie Financial first reported a position in GH in Q4 2020 and held it in 12 quarters. The position peaked at $5.45M in Q1 2026. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Mackenzie Financial reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
Mackenzie Financial sold 59,025 Guardant Health shares in Q2 2026, an estimated $5.45M.
Mackenzie Financial first reported a position in Guardant Health in Q4 2020 and held it in 12 quarters.
Mackenzie Financial's Guardant Health position peaked at $5.45M in Q1 2026.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.